Polaris Intelligence
Polaris
Intelligence
AboutNational IntelligenceOrganizationsProductsMissionsSpacecraftConstellationsForecastsLatest Information
Explore
© Polaris Intelligence 2026Admin

Latest Information

Browse the latest facts and intelligence extracted from space industry sources.

InformationArticlePublished

Latest Information

Browse the latest facts and intelligence extracted from space industry sources.

262,937

total items

InformationArticlePublished

EarthDaily Federal plans to advocate for stricter industry-wide data standards and the adoption of Analysis-Ready Data for government GEOINT workflows.

EarthDaily Federal appointed to US space intelligence council as constellation rollout continuesMay 1, 2026

The Space Intelligence Council will focus on updating procurement policies and accelerating the adoption of commercial space technologies for defence operations.

EarthDaily Federal appointed to US space intelligence council as constellation rollout continuesMay 1, 2026

National Security and Technology Memorandum-3 formally launched the National Initiative for American Space Nuclear Power.

The 2028 Deadline Is RealMay 1, 2026

The White House’s April 14 nuclear power memorandum sets deadlines for reactors in orbit by 2028 and on the lunar surface by 2030.

The 2028 Deadline Is RealMay 1, 2026

NASA’s required space reactor program includes an option for a nuclear electric propulsion demonstration.

The 2028 Deadline Is RealMay 1, 2026

Within 30 days of National Security and Technology Memorandum-3, NASA must formally initiate a program to develop a mid-power space reactor.

The 2028 Deadline Is RealMay 1, 2026

NASA and the Department of Energy have developed nuclear space power concepts in-house and through national laboratories since the Kilopower program began in earnest after 2015.

The 2028 Deadline Is RealMay 1, 2026

Executive Order 14369 is titled "Ensuring American Space Superiority."

The 2028 Deadline Is RealMay 1, 2026

National Security and Technology Memorandum-3 directs NASA, the Department of Energy, and the Department of Defense to coordinate on design, development, testing, and training requirements for space nuclear power.

The 2028 Deadline Is RealMay 1, 2026

National Security and Technology Memorandum-3 directs NASA, the Department of Energy, and the Department of Defense to leverage private industry resources where possible.

The 2028 Deadline Is RealMay 1, 2026

The National Security and Technology Memorandum-3 framework adds a commercial development lane alongside the government-led nuclear space power track.

The 2028 Deadline Is RealMay 1, 2026

The vendor selection window for America’s first orbital nuclear power system opened in Colorado Springs on April 14, 2026.

The 2028 Deadline Is RealMay 1, 2026

NASA’s required space reactor program includes a lunar Fission Surface Power variant ready for launch by 2030.

The 2028 Deadline Is RealMay 1, 2026

Sateliot and Telefónica España are developing a hybrid architecture that combines terrestrial and mobile networks with Low-Earth Orbit satellites.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot has launched six satellites using 3GPP standards and plans to launch five more in 2026.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot raised 100 million euros to fund a 16-satellite constellation for IoT use cases and to serve as a demonstrator for 5G NR technology incorporating voice, video, and data.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot is based in Spain.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot previously demonstrated roaming between Telefónica’s network and Sateliot’s satellite network using a standard SIM card in 2023.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

The Sateliot-Telefónica España collaboration focuses on solutions that use the 5G new radio non-terrestrial networks standard.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot has signed an agreement with Telefónica España to use satellite IoT connectivity to expand Telefónica España’s network in remote areas and for security and defense uses.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

BioOrbit is developing space-drug manufacturing capabilities to reformulate drugs for self-administration by patients.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan signed the first in-orbit pharmaceutical royalty agreement.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan was appointed president of BioOrbit.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin also worked for CASIS as a director working with the ISS National Lab.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit built BOX, a microwave-sized autonomous manufacturing unit that can fly to space and produce crystallized cancer drugs inside a reentry vehicle or commercial space station.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit sent its first BOX to space aboard The Exploration Company’s Nyx spacecraft last year.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit hopes to secure co-development contracts with pharmaceutical companies before its drugs reach the market.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit plans to open an office on the East Coast of the United States.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit expects to fly as many as two missions in 2027.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit expects the regulatory process to take about five years before clinical trials can begin.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin was appointed chief science officer of BioOrbit.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit is building terrestrial drug manufacturing capabilities.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit was founded in 2023.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit’s primary targets are anti-cancer antibodies.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit’s seed round included participation from Auxxo, Seedcamp, Type One Ventures, 7percent Ventures, and undisclosed angel investors.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit is scheduled to send its second mission to orbit this year.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit raised £9.8 million (€11.4 million) in seed funding.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

LocalGlobe and BREEGA co-led BioOrbit’s £9.8 million (€11.4 million) seed round.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan previously worked on Redwire’s business development team.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin spent two decades at Eli Lilly.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit hired two former Redwire veterans to help it pursue contracts with large pharmaceutical firms.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Jorge Ciccorossi is Head of the Space Strategy and Sustainability Division at the ITU Radiocommunications Bureau in Geneva.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

The FCC’s April 2026 decision will shape how WRC-27 addresses spectrum sharing between LEO and GEO systems.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi served as the ITU Radiocommunications Bureau’s spokesperson on satellite issues at WRC-23.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi completed an Executive Certificate in Management and Leadership at MIT.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

SIRRS is the first intergovernmental online platform for reporting radio frequency interference affecting satellite systems.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi studied satellite communications and spacecraft design at the University of Surrey.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Argus is a visualization system that tracks the deployment of large non-geostationary constellations in near real time.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

The FCC voted in April 2026 to replace 1990s-era power limits with a performance-based coordination framework for LEO operators.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi built SIRRS and Argus for the ITU Radiocommunications Bureau.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

EarthDaily Federal plans to advocate for stricter industry-wide data standards and the adoption of Analysis-Ready Data for government GEOINT workflows.

EarthDaily Federal appointed to US space intelligence council as constellation rollout continuesMay 1, 2026

The Space Intelligence Council will focus on updating procurement policies and accelerating the adoption of commercial space technologies for defence operations.

EarthDaily Federal appointed to US space intelligence council as constellation rollout continues
Previous
Page4of5259
Next
May 1, 2026

National Security and Technology Memorandum-3 formally launched the National Initiative for American Space Nuclear Power.

The 2028 Deadline Is RealMay 1, 2026

The White House’s April 14 nuclear power memorandum sets deadlines for reactors in orbit by 2028 and on the lunar surface by 2030.

The 2028 Deadline Is RealMay 1, 2026

NASA’s required space reactor program includes an option for a nuclear electric propulsion demonstration.

The 2028 Deadline Is RealMay 1, 2026

Within 30 days of National Security and Technology Memorandum-3, NASA must formally initiate a program to develop a mid-power space reactor.

The 2028 Deadline Is RealMay 1, 2026

NASA and the Department of Energy have developed nuclear space power concepts in-house and through national laboratories since the Kilopower program began in earnest after 2015.

The 2028 Deadline Is RealMay 1, 2026

Executive Order 14369 is titled "Ensuring American Space Superiority."

The 2028 Deadline Is RealMay 1, 2026

National Security and Technology Memorandum-3 directs NASA, the Department of Energy, and the Department of Defense to coordinate on design, development, testing, and training requirements for space nuclear power.

The 2028 Deadline Is RealMay 1, 2026

National Security and Technology Memorandum-3 directs NASA, the Department of Energy, and the Department of Defense to leverage private industry resources where possible.

The 2028 Deadline Is RealMay 1, 2026

The National Security and Technology Memorandum-3 framework adds a commercial development lane alongside the government-led nuclear space power track.

The 2028 Deadline Is RealMay 1, 2026

The vendor selection window for America’s first orbital nuclear power system opened in Colorado Springs on April 14, 2026.

The 2028 Deadline Is RealMay 1, 2026

NASA’s required space reactor program includes a lunar Fission Surface Power variant ready for launch by 2030.

The 2028 Deadline Is RealMay 1, 2026

Sateliot and Telefónica España are developing a hybrid architecture that combines terrestrial and mobile networks with Low-Earth Orbit satellites.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot has launched six satellites using 3GPP standards and plans to launch five more in 2026.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot raised 100 million euros to fund a 16-satellite constellation for IoT use cases and to serve as a demonstrator for 5G NR technology incorporating voice, video, and data.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot is based in Spain.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot previously demonstrated roaming between Telefónica’s network and Sateliot’s satellite network using a standard SIM card in 2023.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

The Sateliot-Telefónica España collaboration focuses on solutions that use the 5G new radio non-terrestrial networks standard.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

Sateliot has signed an agreement with Telefónica España to use satellite IoT connectivity to expand Telefónica España’s network in remote areas and for security and defense uses.

Sateliot and Telefónica España to Explore 5G Satellite Connectivity for Defense, Military UsesMay 1, 2026

BioOrbit is developing space-drug manufacturing capabilities to reformulate drugs for self-administration by patients.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan signed the first in-orbit pharmaceutical royalty agreement.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan was appointed president of BioOrbit.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin also worked for CASIS as a director working with the ISS National Lab.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit built BOX, a microwave-sized autonomous manufacturing unit that can fly to space and produce crystallized cancer drugs inside a reentry vehicle or commercial space station.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit sent its first BOX to space aboard The Exploration Company’s Nyx spacecraft last year.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit hopes to secure co-development contracts with pharmaceutical companies before its drugs reach the market.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit plans to open an office on the East Coast of the United States.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit expects to fly as many as two missions in 2027.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit expects the regulatory process to take about five years before clinical trials can begin.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin was appointed chief science officer of BioOrbit.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit is building terrestrial drug manufacturing capabilities.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit was founded in 2023.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit’s primary targets are anti-cancer antibodies.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit’s seed round included participation from Auxxo, Seedcamp, Type One Ventures, 7percent Ventures, and undisclosed angel investors.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit is scheduled to send its second mission to orbit this year.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit raised £9.8 million (€11.4 million) in seed funding.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

LocalGlobe and BREEGA co-led BioOrbit’s £9.8 million (€11.4 million) seed round.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Molly Mulligan previously worked on Redwire’s business development team.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Ken Savin spent two decades at Eli Lilly.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

BioOrbit hired two former Redwire veterans to help it pursue contracts with large pharmaceutical firms.

BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in OrbitMay 1, 2026

Jorge Ciccorossi is Head of the Space Strategy and Sustainability Division at the ITU Radiocommunications Bureau in Geneva.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

The FCC’s April 2026 decision will shape how WRC-27 addresses spectrum sharing between LEO and GEO systems.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi served as the ITU Radiocommunications Bureau’s spokesperson on satellite issues at WRC-23.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi completed an Executive Certificate in Management and Leadership at MIT.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

SIRRS is the first intergovernmental online platform for reporting radio frequency interference affecting satellite systems.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi studied satellite communications and spacecraft design at the University of Surrey.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Argus is a visualization system that tracks the deployment of large non-geostationary constellations in near real time.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

The FCC voted in April 2026 to replace 1990s-era power limits with a performance-based coordination framework for LEO operators.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026

Jorge Ciccorossi built SIRRS and Argus for the ITU Radiocommunications Bureau.

SmallSat Europe Speaker Focus: Jorge Ciccorossi, ITU Radiocommunications BureauMay 1, 2026